Show simple item record

The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey.

dc.contributor.authorİNCE, Fatma Birsen
dc.date.accessioned2021-03-02T22:55:16Z
dc.date.available2021-03-02T22:55:16Z
dc.identifier.citationİNCE F. B. , "The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey.", ISPOR 18th Annual International Meeting, New Orleans, Amerika Birleşik Devletleri, 18 - 22 Mayıs 2013, ss.285
dc.identifier.othervv_1032021
dc.identifier.otherav_0f7acbea-96ff-47f1-a946-b3a91bef0654
dc.identifier.urihttp://hdl.handle.net/20.500.12627/15943
dc.language.isoeng
dc.subjectÇOK DİSİPLİNLİ BİLİMLER
dc.subjectTemel Bilimler
dc.subjectDoğa Bilimleri Genel
dc.subjectTemel Bilimler (SCI)
dc.titleThe cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey.
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID318647


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record